Monday, June 11, 2012

Podcast: Influencing the Real Decision Makers: 7 Lenses For Marketing Health to Women


In this episode, Taren Grom, Editor-in-Chief of PharmaVOICE, leads a discussion that focuses on a recent study on women's views and practices regarding health and health decisions for their families. The study uncovered seven lenses for marketing health to women. You'll come away with new insights into women's actual role as decision makers, caregivers, and medical and financial executives in their families. Plus, you will discover how to apply these new findings to create more effective marketing and market research programs for your brand or franchise.

For more information about SSI, visit
www.surveysampling.com.

Download Podcast
Download Podcast Transcript (PDF)

See All PharmaVOICE podcasts

Wednesday, May 2, 2012

White Paper - Top Ten Myths in Clinical Trial Enrollment and Retention


This white paper discusses how the efficiency with which investigator sites enroll patients is still one of the most critical drivers of timely trial completion.

For more information about Acurian, visit www.acurian.com.

Download Whitepaper

See All PharmaVOICE whitepapers

Download Companion Podcast - Top Ten Patient Enrollment and Retention Myths 

Download Podcast Transcript (PDF)


Podcast: Top Ten Patient Enrollment and Retention Myths


In this episode, Scott Connor shares 4 of his top 10 myths about patient enrollment and retention, and we'll tell you where to get the entire list.

For more information about Acurian, visit
www.acurian.com.

Download Podcast

Download Podcast Transcript (PDF)

See All PharmaVOICE podcasts

Download Companion Whitepaper - Top Ten Myths in Clinical Trial Enrollment and Retention

Tuesday, May 1, 2012

DIA 2012 48th Annual Meeting Preview Podcast


In this episode of the PharmaVOICE Executive Suite Podcast Series, Craig Lipset shares his thoughts on being Chairman of the DIA 2012 48th Annual Meeting in June, and how his work at Pfizer helps him in his role with DIA including this year's theme on collaboration. He also comments on how industry trends will impact drug development and clinical trials, and offers a couple tips on getting the most out of this year's DIA Annual Meeting in Philadelphia.
Craig Lipset

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thursday, April 12, 2012

Case Study - Providing Pre-Approval Access Globally


This informative case study covers how best to meet patient demand globally without placing additional burden on internal teams.

For more information about Idis, visit www.idispharma.com.

Download Whitepaper



Download Podcast Transcript (PDF)



Podcast: Patient Access to Investigational Drugs: Removing Barriers

In this episode, Mr. Estcourt shares his perspective on programs that enable patient access to medicines outside the clinical trial or commercial setting and the barriers that remain despite well-defined regulations governing such access.

For more information about Idis, visit
www.idispharma.com.

Download Podcast

Download Podcast Transcript (PDF)

See All PharmaVOICE podcasts

Download Companion Case Study - Providing Pre-Approval Access Globally

Tuesday, April 3, 2012

White Paper - Seize the Moment: Tele-Sales Solutions Delivering Impact and Flexibility


This white paper illustrates how tele-sales solutions provide valuable interactions and develop relationships with healthcare providers and their offices in customized ways that meet their individual needs.

For more information about Tele-Sales Solutions, visit www.phonescreen.com.

Download Whitepaper

See All PharmaVOICE whitepapers

Download Companion Podcast - Insights from the Field: Tele-Sales Solutions Build Relationships between the Brand and HCPs 

Download Podcast Transcript (PDF)

All Podcasts and White Papers

PhoneScreen is a Tunstall AMAC company. 

Podcast - Insights from the Field: Tele-Sales Solutions Build Relationships between the Brand and HCPs

In this episode, Mr. Shapiro talks about the challenges life science companies face when providing information on their products to physicians and healthcare providers.

For more information about PhoneScreen, visit
www.phonescreen.com.

Download Podcast

Download Podcast Transcript (PDF)

See All PharmaVOICE podcasts

Download Companion Whitepaper - Seize the Moment: Tele-Sales Solutions Delivering Impact and Flexibility

Thursday, February 2, 2012

White Paper - Understanding Drug-Induced Liver Injury in the Context of Pharmaceutical Development


This whitepaper discusses drug-induced liver injuries within pharmaceutical development.

For more information about PPD, visit http://www.ppdi.com/.

White Paper - Adaptive Social Media in Pharma

This white paper discusses using adaptive social media in the pharmaceutical industry.

For more information about Cognizant, visit http://www.cognizant.com/.

Podcast: Understanding the Impact of Drug Induced Liver Injury on Drug Development

In this episode, Dr. Lobel talks about Drug-induced liver injury, also known as DILI. We'll cover what DILI is, how it is identified, and its effects on the clinical development process. At the end of this podcast, you'll learn where you can download a related white paper on this topic.

For more information about PPD, visit
www.ppdi.com.

Podcast: The Evolving Social Media Lifecycle in Pharma

In this episode, a trio of experts from Cognizant talk about numerous issues involving social media in the life sciences. There is also a related white paper you may download.

For more information about Cognizant, visit
www.cognizant.com.

White Paper - Transforming R&D Productivity by Re-defining Success in Clinical Trial Enrollment

It may come as a surprise to many pharmaceutical industry experts that the largest portion of an R&D sponsor's investment and the biggest driver of trial budgets is patient enrollment at 32% of trial costs . To those who are already aware of this, it may still be surprising that innovation required to improve this disproportionate budget allocation is already available.

For more information about Acurian, visit http://www.acurian.com/.


Podcast: How the New Role of the CRO Affects Patient Enrollment

In this episode, Dr. Malcolm discusses how the role of the CRO is transitioning from commodity service supplier to strategic partner, and the unintended negative consequences this could have on what is already the most expensive part of clinical trials: patient enrollment.

For more information about Acurian, visit
www.acurian.com.


White Paper - ePRO for Late Phase, Post-Approval Market

For ePRO and patients around the world, it's a perfect storm of good news.

For more information about PHT Corp., visit http://www.phtcorp.com/.

Download Whitepaper
See All PharmaVOICE whitepapers

Podcast: Transformative Leadership

In this episode, Dr. Dunsire shares her insights on the quest to find a cure for cancer, on women striving for positions in the C-Suite, and thoughts on her own career development and recognition as the 2009 HBA Woman of the Year.

For more information about Millennium, visit
www.millennium.com.

Download Podcast

See All PharmaVOICE podcasts

Tuesday, January 10, 2012

White Paper - Envisioning a New Commercial Model: Is it Right for Your Brand

As the pace and scope of change within the healthcare life sciences continue to increase, many are questioning the validity of traditional "fundamentals" of the life sciences commercialization model for connecting brands with healthcare professionals, consumers, and economic customers. In this PharmaVoice digital feature, Will Reese and Steve Wray of Cadient Group analyze the core issues for life sciences commercial stakeholders facing the challenges of an ever-changing environment.

For more information about Cadient, visit http://www.cadient.com/.

Download Whitepaper
See All PharmaVOICE whitepapers

Wednesday, January 4, 2012

White Paper - Large Pharma & Healthcare Company Uses Aravo for Due Diligence on FCPA Compliance and Critical Lifecycle Management Automation

A large pharmaceutical company faced a serious potential problem with FCPA compliance and partner due diligence processes. Through creation of a rigorous best practice FCPA program, the company was able to significantly mitigate their exposure through execution of an enhanced compliance plan.

For more information about Aravo, visit
www.aravo.com.

Download Whitepaper
See All PharmaVOICE whitepapers

Download Companion Podcast - Automating Pharma FCPA Due Diligence

Download Podcast Transcript (PDF)